1. Synthesis and glycosidase inhibition of 3,4,5-trihydroxypiperidines using a one-pot amination-cyclisation cascade reaction.
- Author
-
Dangerfield EM, Meijlink MA, Hunt-Painter AA, Nasseri SA, Withers SG, Stocker BL, and Timmer MSM
- Subjects
- Amination, Cyclization, Glycoside Hydrolases antagonists & inhibitors, Glycoside Hydrolases metabolism, Escherichia coli drug effects, Escherichia coli enzymology, Molecular Structure, Piperidines chemistry, Piperidines pharmacology, Piperidines chemical synthesis, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors pharmacology, Enzyme Inhibitors chemistry
- Abstract
Trihydroxypiperidines are a therapeutically valuable class of iminosugar. We applied a one-pot amination-cyclisation cascade reaction to synthesise 3,4,5-trihydroxypiperidine stereoisomers in three steps from commercially available pentoses and in excellent overall yields. Using our methodology, the yields of the syntheses of meso-1, meso-2 and 3L are the highest reported to date. The synthetic methodology was readily extended to the three-step synthesis of N-alkyl derivatives by replacing the ammonia nitrogen source with a primary amine. The trihydroxypiperidines and N-alkyl analogues were screened for enzyme inhibitory activity using Fabrazyme (Fabry disease), GCase (Gaucher's disease), Agrobacterium sp. β-glucosidase, and Escherichia coli β-galactosidase. N-Phenylethyl 3,4,5-trihydroxypiperidine (N-phenylethyl-1-(3R,4R,5S)-piperidine-3,4,5-triol) showed good inhibitory activity of Fabrazyme (K
i = 46 μM). This activity was abolished when the N-phenylethyl group was removed or replaced with a non-aromatic alkyl chain., Competing Interests: Declaration of competing interest The authors y declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF